Skip to content
CNS Clinical Research

Massachusetts

CNS clinical trials in Massachusetts

227 CNS studies are recruiting participants at sites in 34 cities across Massachusetts as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Massachusetts city with a recruiting study

By research area: Depression (101), Multiple Sclerosis (26), Parkinson's Disease (26), Epilepsy (25), Schizophrenia (23), ADHD (12), Migraine (11), Bipolar Disorder (3).

Boston (153), Belmont (23), Worcester (21), Watertown (18), Charlestown (11), Foxborough (11), Cambridge (5), Springfield (5), Waltham (4), Burlington (3), Russells Mills (2), Wellesley (2), Westborough (2), Allston (1), Beverly (1), Brockton (1), Chelsea (1), Chestnut Hill (1), Fall River (1), Gloucester (1), Hyde Park (1), Leominster (1), Lowell (1), Methuen (1), Needham (1), Newburyport (1), Norfolk (1), North Dartmouth (1), North Worcester (1), Peabody (1), Roslindale (1), Shrewsbury (1), Stoneham (1), Worchester (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Massachusetts

Basic details from each study's public record (the 12 most recently updated of 227). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 85
    • All sexes
    Sponsor
    Cybin IRL Limited
    Recruiting in
    Boston · Watertown
    Registry record
    NCT06793397 · updated
  2. Longitudinal Assessment of Biomarkers Among Patients With MDD

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Massachusetts General Hospital
    Recruiting in
    Boston
    Registry record
    NCT07931001 · updated
  3. Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Massachusetts General Hospital
    Recruiting in
    Boston
    Registry record
    NCT05450432 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Massachusetts on ClinicalTrials.gov.

Schizophrenia: recently updated in Massachusetts

  1. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

    • Phase 3
    • Ages 13 to 17
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Boston
    Registry record
    NCT07288567 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Massachusetts on ClinicalTrials.gov.

ADHD: recently updated in Massachusetts

  1. The Myelin Disorders Biorepository Project

    • Observational
    • All ages
    • All sexes
    Sponsor
    Children's Hospital of Philadelphia
    Recruiting in
    Boston
    Registry record
    NCT03047369 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Massachusetts on ClinicalTrials.gov.

Parkinson's disease: recently updated in Massachusetts

  1. DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    AstraZeneca
    Recruiting in
    Boston
    Registry record
    NCT06989112 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Massachusetts on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in Massachusetts

  1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Boston
    Registry record
    NCT03816345 · updated
  2. A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Zenas BioPharma (USA), LLC
    Recruiting in
    Worcester
    Registry record
    NCT07299019 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Massachusetts on ClinicalTrials.gov.

Epilepsy: recently updated in Massachusetts

  1. Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

    • Phase 4
    • Ages 18 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Boston
    Registry record
    NCT04419272 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Massachusetts on ClinicalTrials.gov.

Migraine: recently updated in Massachusetts

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Mayo Clinic
    Recruiting in
    Hyde Park
    Registry record
    NCT06972056 · updated
  2. Study of EVO756 in Adults With Migraine

    • Phase 2
    • Ages 18 to 64
    • All sexes
    Sponsor
    Evommune, Inc.
    Recruiting in
    Foxborough · Westborough
    Registry record
    NCT07616128 · updated
  3. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Fall River · Foxborough
    Registry record
    NCT07816367 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Massachusetts on ClinicalTrials.gov.

Ask about studies in Massachusetts

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call